Skip to content

Use Of The ABSS In Infants With ARIS Treated With Outpatient Respiratory Physiotherapy

Use Of The Acute Bronchiolitis Severity Scale In Infants With Acute Respiratory Infection Susceptible To Outpatient Respiratory PhysiotherapyTreatment

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04036591
Enrollment
32
Registered
2019-07-30
Start date
2019-02-26
Completion date
2021-05-31
Last updated
2019-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Disease Respiratory

Keywords

Clinical scale, infant, respiratory therapy

Brief summary

Background. Acute respiratory infections in childhood have high incidence and morbimortality rates, generating significant sanitary and social costs. Due to its diversity of manifestations and clinical forms, the degree of severity varies widely. Published acute respiratory infections assessment severity scales are mainly focused on acute bronchiolitis, but there is no validated scale to evaluate the effects of respiratory physiotherapy in acute respiratory infections in children. Objective. To study the usefulness of the Acute Bronchiolitis Severity Scale to assess children under 24 months suffering from acute respiratory infections susceptible to receive outpatient respiratory physiotherapy treatment. Methods. Pre-post assessment descriptive study using the Acute Bronchiolitis Severity Scale. Children under 24 months suffering from acute respiratory infection will be evaluated during the first outpatient respiratory physiotherapy treatment.

Interventions

DIAGNOSTIC_TESTAcute Bronchiolitis Severity Scale (ABSS)

All infants will be assessed using the Acute Bronchiolitis Severity Scale (ABSS) before and after being treated by experienced physiotherapists using the prolonged slow expiration technique and provoqued cough. Before the application of these techniques a retrograde rhinopharyngeal unclogging will be performed in order to clean the nasopharynx.

Sponsors

Neumomadrid
CollaboratorUNKNOWN
Universidad Complutense de Madrid
CollaboratorOTHER
FisioRespiración
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
1 Days to 24 Months
Healthy volunteers
No

Inclusion criteria

* Under 24 months * ARIS diagnosed * Medical indication of respiratory physiotherapy * Evaluated during the first outpatient respiratory physiotherapy treatment

Exclusion criteria

* Chronic desease * ABSS ≥ 7 * Temperature≥ 38ºC * Stridor * Expiratory groan * Sternal sinking * Any sign or symptom indicative of need for urgent medical evaluation

Design outcomes

Primary

MeasureTime frameDescription
Usefulness of Acute Bronchiolitis Severity Score (ABSS) to asses children under 24 months suffering from acute respiratory infection susceptible to receive outpatient respiratory physiotherapy treatment.Through study completion, an average of 2 years.Physiotherapists will use the Acute Bronchiolitis Severity Score (ABSS) to assess severity of infection pre and post treatment. After several assessments each one of them will inform about the usefulness and aplicability of the scale in outpatient respiratory physiotherapy treatment by filling in a likert scale (usefulness, aplicability, simplicity, time required...)
Immediate effectiveness of outpatient respiratory physiotherapy treatment.Measurements will be taken during the outpatient respiratory physiotherapy treatment, 1 hour approximately. Pre treatment data will be collected before starting the treatment and post data 5 minutes after finishing the last manouver.Change from baseline in the Acute Bronchiolitis Severity Score (ABSS) punctuation at the end of outpatient respiratory physiotherapy treatment (pre-post treatment measurement of the scale). The ABSS is a validated scale in a Spanish population that combines the evaluation of heart and respiratory rate, wheezings, crackles, respiratory effort and inspiration/exhalation ratio. It has three levels of severity: mild (0 to 4 points), moderate (5 to 9) and severe (10 to 13).

Countries

Spain

Contacts

Primary ContactBeatriz Simón Rodríguez
beatriz_simon@fisiorespiracion.es0034629441102

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026